Back to dashboard
CommercialCoverageMedium impact

08.00.45f, Eptinezumab-jjmr (VYEPTI™)

Independence Blue Cross·Neurology, Family Medicine, Internal Medicine·Pharmacy
Effective date
Apr 6, 2026
We identified it
Jun 19, 2026
Days to comply
—

Summary

Medical necessity criteria for Eptinezumab-jjmr (VYEPTI™) have been updated for commercial plans. This affects coverage requirements for this migraine prevention medication, potentially changing approval processes for prescriptions.

Action Required

Action needed
By April 6, 2026: Billing team must review updated medical necessity criteria for Eptinezumab-jjmr (VYEPTI™) prescriptions. Update prior authorization workflows and ensure providers document required medical necessity criteria per new policy guidelines. Verify coverage requirements before submitting claims to avoid denials.

Related policy hubs